Skip to content
  • Reports
  • Podcast Subscribe
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Gilead

Gilead

ADVERTISEMENT
News and Trends

Gilead to acquire remaining worldwide rights of breast cancer drug, Trodelvy

All of Everest Medicine's development and commercialization rights for a breast cancer drug called Trodelvy…

By Liza Laws
August 19, 2022 - 3 minutes
News and Trends

Galapagos and Gilead Soldier On After Inflammatory Disease Flops

Clinical and regulatory setbacks have left the star biotech duo Gilead and Galapagos smarting and…

By Victor Kotsev
March 4, 2021 - 4 minutes
News and Trends

Galapagos’ Arthritis Drug Approved in EU and Japan Amid US Rejection

The recent EU and Japan approvals of the rheumatoid arthritis drug filgotinib contrast with the…

By Jonathan Smith
October 5, 2020 - 5 minutes
News and Trends

Remdesivir Becomes the First Covid-19 Treatment Approved in Europe

Remdesivir has received a one-year conditional marketing authorization from the European Commission due to the…

By Victor Kotsev
July 8, 2020 - 3 minutes
News and Trends

Gilead Pays Billions for Access to Galapagos’ Pipeline

Gilead has launched a 10-year collaboration with the Belgo-Dutch biotech Galapagos, paying at least €4.5B…

By Jonathan Smith
July 15, 2019 - 2 minutes
News and Trends

Belgian and US Biotechs Team up to Reduce CAR T Side Effects

The diagnostics company Biocartis is collaborating with Kite Pharma to monitor the progress of CAR…

By Jonathan Smith
June 3, 2019 - 3 minutes
News and Trends

Austrian Biopharma Reaches First HIV Vaccine Milestone

Hookipa Pharma has reached its first milestone in a partnership deal with US-based CAR T…

By Helen Albert
January 3, 2019 - 2 minutes
News and Trends

Galapagos and Gilead Launch the Fifth New Trial for Filgotinib this Year

With the addition of uveitis, Galapagos and Gilead are raising to 10 the number of…

By Clara Rodríguez Fernández
July 5, 2017 - 1 minute
News and Trends

Dual HIV Therapy: GSK and Gilead Battle over Whose Drug is the Best

GSK announced Phase III results for dolutegravir, which could reduce triple HIV therapy down to…

By Clara Rodríguez Fernández
February 14, 2017 - 2 minutes
News and Trends

Galapagos gets another Milestone Payment from Gilead

Galapagos is starting a new PhaseIIb/III clinical trial for ulcerative colitis that has triggered a €9.4M…

By Clara Rodríguez Fernández
December 9, 2016 - 2 minutes
News and Trends

Galapagos Hangs On: Filgotinib enters Phase III for Rheumatoid Arthritis

After losing AbbVie as a partner, Galapagos has pressed on with Gilead in the development…

By Evelyn Warner
August 25, 2016 - 2 minutes
News and Trends

While working on its HIV Cure, Gilead gives Europe an ‘HIV Vaccine’

Despite progress in HIV treatments and towards an HIV cure, the infection rate has risen…

By Evelyn Warner
August 24, 2016 - 2 minutes
  • 1
  • 2
  • Next Page »
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Gene therapy Synthetic biology
    Labiotech.eu
    • Log In

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast
    • Biotech Events
    • Awareness Days